Back to search results

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Abroad (travel likely)RecruitingPHASE1

Conditions

Insulin Resistance · Prediabetic State · Overweight and Obesity · Non-Alcoholic Fatty Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Columbia University Irving Medical Center, New York, New York, United States

    Contact: Study coordinator (Joshua R Cook, MD, PhD) · jrc2175@cumc.columbia.edu · 212-305-6289
    Contact: Study coordinator (Ishwari Nagnur) · zds2120@cumc.columbia.edu · 2123059336
    Contact: Principal Investigator (Joshua R Cook, MD, PhD)
    Blandine Laferrère, MD, PhD (Sub-investigator)
    Henry N Ginsberg, MD (Sub-investigator)
    Julia J Wattacheril, MD (Sub-investigator)
Study leads

  • Joshua R Cook, MD, PhD

    Principal Investigator

    Columbia University

View source on ClinicalTrials.gov(opens in a new tab)